Face2Gene vs AHA PALS
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Face2Gene
This app assists healthcare professionals in performing comprehensive genetic evaluations by detecting dysmorphic features and revealing related traits. It aids in discovering relevant genetic disorders and offers collaborative case review forums for diagnostic dilemmas. The tool is designed for informational purposes and requires medical training to use.
- Deep phenotyping for patient evaluation
- Detect dysmorphic features and traits
- Discover related genetic disorders
- Access London Medical Database
- Collaborative case review forums
- HIPAA and GDPR compliant
Read full descriptionHide full description
*** Face2Gene is designated to be used solely by healthcare professionals and should not be used by anyone without proper medical training. *** A phenotyping app that facilitates comprehensive and precise genetic evaluations. The Face2Gene app includes the following features: Clinic – Enhanced Patient Evaluation with Deep Phenotyping * Detect Dysmorphic Features & Reveal Related Traits * Discover Relevant Genetic Disorders * Includes London Medical Database (LMD) * Access to the Pediatrician View Forums - Collaborative Case Review for Diagnostic Dilemmas * Share cases in secure group forums * Comment on other cases and receive feedback on your cases * Community created solely for health care professionals Compliant with HIPAA and GDPR privacy rules and standards. Face2Gene is a search & reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.
AHA PALS
This app provides pediatric advanced life support (PALS) protocols and tools for healthcare professionals at the point-of-care. Developed by physicians and vetted by the American Heart Association, it offers intuitive access to algorithms, drug information, and timers for critical care situations.
- PALS pathways and algorithms
- Drug therapy and dosing
- CPR and intervention timers
- Metronome for compression accuracy
- Critical care references
- Vetted by AHA and physicians
Read full descriptionHide full description
We continue to iterate based on real-time clinician feedback so that you will have the best experience providing life-saving care at the bedside. The AHA PALS app was developed by Harvard-trained physicians, in collaboration with the American Heart Association (AHA), to help fellow physicians, physician assistants, nurse practitioners, and emergency medical technicians (EMT) deliver the highest level of pediatric advanced life support (PALS) at the point-of-care. This project was inspired by the tremendous success of our AHA ACLS app, which has thousands of clinician users in over 180 countries. Importantly, real-time feedback from our clinician users continuously drives improvements in app design, features, and function. AHA PALS is the only app to have all content vetted by both the American Heart Association (AHA) science team (with license to use PALS content) and practicing Harvard-affiliated physicians. We owe it to our patients to use the best digital health tools to give them the highest chance of surviving acute life-threatening illnesses. To this end, we have developed an intuitive and rigorously vetted mobile app to assist healthcare clinicians—at any stage of training—navigate PALS at the bedside. You can purchase a yearly subscription which begins with a 3-day free trial. After completing the free trial, you will be charged for an annual subscription automatically. Features: - Intuitive design to rapidly access PALS pathways (i.e. cardiac arrest , tachycardia with pulse, bradycardia with pulse, post cardiac arrest care, and critical care references) - Includes all PALS content including drug therapy and dosing, reversible causes, etc. - Easy-to-read timers and ability to log rounds of CPR, epinephrine, and defibrillations. There are additional functionalities to log PALS Cardiac Arrest interventions beyond EPI, CPR , and shocks such as lidocaine and more. - We also added a new metronome feature to improve compression accuracy as well as a ROSC button. - Button within cardiac arrest algorithm that allows for rapid transition to post cardiac arrest care checklist once patient achieves ROSC - Relevant critical care references: (1) drugs used in PALS (i.e., medication names, indications, and doses); (2) vital signs in children; (3) pediatric color-coded length-based resuscitation tape (adapted from Breslow tape) ; (4) pediatric Glasgow Coma Scale - All content rigorously vetted by AHA science team and practicing Harvard-affiliated physicians - Regularly updated with the most up-to-date PALS content
Screenshots
Verdict
The clearest difference is rating: AHA PALS at 4.5 against Face2Gene's 2.1. AHA PALS also leads on review sentiment (55% vs 17%) and chart position (#159 vs unranked). Face2Gene's advantage is in-app purchases (none vs 1). On price, ratings volume, update cadence and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. AHA PALS sells 1 in-app purchase, starting at $3.99 per year. Face2Gene asks for nothing beyond the download.
AHA PALS holds the better App Store score, 4.5 against 2.1. Both are backed by a comparable volume of ratings — 55 and 53 respectively. Written reviews point the same way: 17% of Face2Gene's written reviews are positive against 55% of AHA PALS's.
Face2Gene ships an update every 3 months, AHA PALS every 2 months. The most recent releases landed on October 16, 2026 and October 14, 2026 respectively.
| Parameter | Face2Gene | AHA PALS |
|---|---|---|
| Price | Free | Free |
| Rating | 2.1 (55 ratings) | 4.5 (53 ratings) — better |
| Positive reviews | 16.7% of reviews | 54.5% of reviews — better |
| Number of ratings | 55 — better | 53 |
| Update frequency | Every 3 months | Every 2 months — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free — better | Subscription |
| Best chart rank | — | #159 — better |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 16.6 | 15.1 — better |
| Further details — not scored | ||
| Size | 43 MB | 48 MB |
| Age rating | 17+ | 17+ |
| Developer | FDNA | Massachusetts General Hospital |
Customer experience
Face2Gene
AHA PALS
In-app purchases
Face2Gene
No in-app purchases
AHA PALS
- PALS3 Days trial$3.991 Year









